Uganda Virus Research Institute, Entebbe, Uganda.
MRC/UVRI Uganda Research Unit, Entebbe, Uganda.
BMC Infect Dis. 2018 Feb 27;18(1):93. doi: 10.1186/s12879-018-3001-4.
The World Health Organization recommends that countries conduct two phase evaluations of HIV rapid tests (RTs) in order to come up with the best algorithms. In this report, we present the first ever such evaluation in Uganda, involving both blood and oral based RTs. The role of weak positive (WP) bands on the accuracy of the individual RT and on the algorithms was also investigated.
In total 11 blood based and 3 oral transudate kits were evaluated. All together 2746 participants from seven sites, covering the four different regions of Uganda participated. Two enzyme immunoassays (EIAs) run in parallel were used as the gold standard. The performance and cost of the different algorithms was calculated, with a pre-determined price cut-off of either cheaper or within 20% price of the current algorithm of Determine + Statpak + Unigold. In the second phase, the three best algorithms selected in phase I were used at the point of care for purposes of quality control using finger stick whole blood.
We identified three algorithms; Determine + SD Bioline + Statpak; Determine + Statpak + SD Bioline, both with the same sensitivity and specificity of 99.2% and 99.1% respectively and Determine + Statpak + Insti, with sensitivity and specificity of 99.1% and 99% respectively as having performed better and met the cost requirements. There were 15 other algorithms that performed better than the current one but rated more than the 20% price. None of the 3 oral mucosal transudate kits were suitable for inclusion in an algorithm because of their low sensitivities. Band intensity affected the performance of individual RTs but not the final algorithms.
We have come up with three algorithms we recommend for public or Government procurement based on accuracy and cost. In case one algorithm is preferred, we recommend to replace Unigold, the current tie breaker with SD Bioline. We further recommend that all the 18 algorithms that have shown better performance than the current one are made available to the private sector where cost may not be a limiting factor.
世界卫生组织建议各国对艾滋病毒快速检测(RT)进行两阶段评估,以制定最佳算法。在本报告中,我们首次在乌干达进行了此类评估,涉及血液和口腔 RT。还研究了弱阳性(WP)条带对个体 RT 准确性和算法的影响。
共评估了 11 种血液基础和 3 种口腔渗出试剂盒。来自乌干达四个不同地区的七个地点的总共 2746 名参与者参加了此次研究。两种平行运行的酶联免疫吸附测定(EIA)用作金标准。计算了不同算法的性能和成本,并预先设定了价格折扣,要么更便宜,要么与当前的 Determine + Statpak + Unigold 算法相差 20%以内。在第二阶段,在现场使用第一阶段选择的三种最佳算法进行质量控制,使用指尖全血。
我们确定了三种算法;Determine + SD Bioline + Statpak;Determine + Statpak + SD Bioline,其灵敏度和特异性均为 99.2%和 99.1%,而 Determine + Statpak + Insti 的灵敏度和特异性分别为 99.1%和 99%,表现更好,且符合成本要求。还有 15 种其他算法的性能优于当前算法,但价格超过 20%。由于敏感性低,没有一种口腔黏膜渗出试剂盒适合纳入算法。条带强度会影响个体 RT 的性能,但不会影响最终的算法。
我们根据准确性和成本提出了三种我们建议用于公共或政府采购的算法。如果只选择一种算法,我们建议用 SD Bioline 替代当前的 Tie Breaker Unigold。我们进一步建议,所有性能优于当前算法的 18 种算法都可供私营部门使用,因为成本可能不是一个限制因素。